LAS VEGAS, March 9, 2025 /PRNewswire/ -- C-suite leaders from Houston Methodist and Health Data Analytics Institute (HDAI) will be speaking at…
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also…
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease…
ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and…
A Former Health System CEO, Mr. Statuto Has Over 30 Years of Leadership Experience CHARLES TOWN, W.V., March 7, 2025…
PORTLAND, Maine, March 6, 2025 /PRNewswire/ -- MedRhythms today announced that MR-005, the company's neurorehabilitation system to support gait rehabilitation…
COLUMBUS, Ohio, March 6, 2025 /PRNewswire/ -- Today, clinical trials dramatically underrepresent patients who live in rural areas of the…
FAIRFAX, Va., March 4, 2025 /PRNewswire/ -- Team Goldbelt, comprised of Goldbelt Apex, LLC, Knowesis, Inc., and zCore Business Solutions…
DELRAY BEACH, Fla., March 4, 2025 /PRNewswire/ -- The global AI in Remote Patient Monitoring Market, valued at US$1551.8 million…
DALLAS, March 4, 2025 /PRNewswire/ -- Homecare HomebaseSM (HCHB), the leading software provider for home-based care, has named Janie "Heather"…